{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:40:27Z","timestamp":1790959227831,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:00:00Z","timestamp":1722556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-024-01528-8","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T09:04:32Z","timestamp":1722589472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Integrating bioinformatics and machine learning methods to analyze diagnostic biomarkers for HBV-induced hepatocellular carcinoma"],"prefix":"10.1186","volume":"19","author":[{"given":"Anyin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"issue":"3","key":"1528_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"1528_CR2","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598\u2013606. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.021.","journal-title":"J Hepatol"},{"key":"1528_CR3","doi-asserted-by":"publisher","first-page":"104992","DOI":"10.1016\/j.phrs.2020.104992","volume":"159","author":"L Jia","year":"2020","unstructured":"Jia L, Gao Y, He Y, Hooper JD, Yang P. HBV induced hepatocellular carcinoma and related potential immunotherapy. Pharmacol Res. 2020;159:104992. https:\/\/doi.org\/10.1016\/j.phrs.2020.104992.","journal-title":"Pharmacol Res"},{"issue":"1","key":"1528_CR4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295(1):65\u201373. https:\/\/doi.org\/10.1001\/jama.295.1.65.","journal-title":"JAMA"},{"key":"1528_CR5","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2147\/jhc.S307962","volume":"8","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Han Q, Zhao H, Zhang J. The mechanisms of HBV-Induced Hepatocellular Carcinoma. J Hepatocell Carcinoma. 2021;8:435\u201350. https:\/\/doi.org\/10.2147\/jhc.S307962.","journal-title":"J Hepatocell Carcinoma"},{"issue":"7553","key":"1528_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature14539","volume":"521","author":"Y LeCun","year":"2015","unstructured":"LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521(7553):436\u201344. https:\/\/doi.org\/10.1038\/nature14539.","journal-title":"Nature"},{"issue":"3","key":"1528_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41568-020-00327-9","volume":"21","author":"A Kleppe","year":"2021","unstructured":"Kleppe A, Skrede OJ, De Raedt S, Liest\u00f8l K, Kerr DJ, Danielsen HE. Designing deep learning studies in cancer diagnostics. Nat Rev Cancer. 2021;21(3):199\u2013211. https:\/\/doi.org\/10.1038\/s41568-020-00327-9.","journal-title":"Nat Rev Cancer"},{"issue":"10360","key":"1528_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/s0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362. https:\/\/doi.org\/10.1016\/s0140-6736(22)01200-4.","journal-title":"Lancet"},{"issue":"1 Suppl","key":"1528_CR9","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64(1 Suppl):S84\u2013101. https:\/\/doi.org\/10.1016\/j.jhep.2016.02.021.","journal-title":"J Hepatol"},{"issue":"15","key":"1528_CR10","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450\u201362. https:\/\/doi.org\/10.1056\/NEJMra1713263.","journal-title":"N Engl J Med"},{"issue":"1","key":"1528_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s10120-014-0355-1","volume":"18","author":"S Saigusa","year":"2015","unstructured":"Saigusa S, Tanaka K, Mohri Y, Ohi M, Shimura T, Kitajima T, et al. Clinical significance of RacGAP1 expression at the invasive front of gastric cancer. Gastric Cancer. 2015;18(1):84\u201392. https:\/\/doi.org\/10.1007\/s10120-014-0355-1.","journal-title":"Gastric Cancer"},{"issue":"3","key":"1528_CR12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/carcin\/bgu327","volume":"36","author":"H Imaoka","year":"2015","unstructured":"Imaoka H, Toiyama Y, Saigusa S, Kawamura M, Kawamoto A, Okugawa Y, et al. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer. Carcinogenesis. 2015;36(3):346\u201354. https:\/\/doi.org\/10.1093\/carcin\/bgu327.","journal-title":"Carcinogenesis"},{"issue":"3","key":"1528_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000500592","volume":"97","author":"C Yin","year":"2019","unstructured":"Yin C, Toiyama Y, Okugawa Y, Shigemori T, Yamamoto A, Ide S, et al. Rac GTPase-Activating protein 1 (RACGAP1) as an oncogenic enhancer in esophageal carcinoma. Oncology. 2019;97(3):155\u201363. https:\/\/doi.org\/10.1159\/000500592.","journal-title":"Oncology"},{"issue":"1","key":"1528_CR14","doi-asserted-by":"publisher","first-page":"112493","DOI":"10.1016\/j.yexcr.2021.112493","volume":"400","author":"K Ren","year":"2021","unstructured":"Ren K, Zhou D, Wang M, Li E, Hou C, Su Y, et al. RACGAP1 modulates ECT2-Dependent mitochondrial quality control to drive breast cancer metastasis. Exp Cell Res. 2021;400(1):112493. https:\/\/doi.org\/10.1016\/j.yexcr.2021.112493.","journal-title":"Exp Cell Res"},{"key":"1528_CR15","doi-asserted-by":"publisher","unstructured":"Gu Y, Chen B, Guo D, Pan L, Luo X, Tang J, et al. Up-Regulation of RACGAP1 promotes progressions of Hepatocellular Carcinoma regulated by GABPA via PI3K\/AKT pathway. Oxid Med Cell Longev. 2022;2022(3034150). https:\/\/doi.org\/10.1155\/2022\/3034150.","DOI":"10.1155\/2022\/3034150"},{"issue":"4","key":"1528_CR16","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/cimb44040115","volume":"44","author":"S Zabady","year":"2022","unstructured":"Zabady S, Mahran N, Soltan MA, Alaa Eldeen M, Eid RA, Albogami S, et al. Cyanidin-3-Glucoside modulates hsa_circ_0001345\/miRNA106b\/ATG16L1 Axis expression as a potential protective mechanism against Hepatocellular Carcinoma. Curr Issues Mol Biol. 2022;44(4):1677\u201387. https:\/\/doi.org\/10.3390\/cimb44040115.","journal-title":"Curr Issues Mol Biol"},{"issue":"2","key":"1528_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41419-021-03450-z","volume":"12","author":"D Xu","year":"2021","unstructured":"Xu D, Wang Y, Wu J, Zhang Z, Chen J, Xie M, et al. ECT2 overexpression promotes the polarization of tumor-associated macrophages in hepatocellular carcinoma via the ECT2\/PLK1\/PTEN pathway. Cell Death Dis. 2021;12(2):162. https:\/\/doi.org\/10.1038\/s41419-021-03450-z.","journal-title":"Cell Death Dis"},{"issue":"6","key":"1528_CR18","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.jhep.2015.01.014","volume":"62","author":"J Chen","year":"2015","unstructured":"Chen J, Xia H, Zhang X, Karthik S, Pratap SV, Ooi LL, et al. ECT2 regulates the Rho\/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma. J Hepatol. 2015;62(6):1287\u201395. https:\/\/doi.org\/10.1016\/j.jhep.2015.01.014.","journal-title":"J Hepatol"},{"issue":"1","key":"1528_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s12032-016-0872-3","volume":"34","author":"Z Guo","year":"2017","unstructured":"Guo Z, Chen X, Du T, Zhu D, Lai Y, Dong W, et al. Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer. Med Oncol. 2017;34(1):13. https:\/\/doi.org\/10.1007\/s12032-016-0872-3.","journal-title":"Med Oncol"},{"key":"1528_CR20","doi-asserted-by":"publisher","unstructured":"Huff LP, Decristo MJ, Trembath D, Kuan PF, Yim M, Liu J, et al. The role of Ect2 Nuclear RhoGEF activity in Ovarian Cancer Cell Transformation. Genes Cancer. 2013;4(11\u201312). https:\/\/doi.org\/10.1177\/1947601913514851. 460\u2009\u2013\u200975.","DOI":"10.1177\/1947601913514851"},{"issue":"11","key":"1528_CR21","doi-asserted-by":"publisher","first-page":"e14082","DOI":"10.1371\/journal.pone.0014082","volume":"5","author":"M Iyoda","year":"2010","unstructured":"Iyoda M, Kasamatsu A, Ishigami T, Nakashima D, Endo-Sakamoto Y, Ogawara K, et al. Epithelial cell transforming sequence 2 in human oral cancer. PLoS ONE. 2010;5(11):e14082. https:\/\/doi.org\/10.1371\/journal.pone.0014082.","journal-title":"PLoS ONE"},{"issue":"7","key":"1528_CR22","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12094-015-1428-2","volume":"18","author":"HB Wang","year":"2016","unstructured":"Wang HB, Yan HC, Liu Y. Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients. Clin Transl Oncol. 2016;18(7):735\u201342. https:\/\/doi.org\/10.1007\/s12094-015-1428-2.","journal-title":"Clin Transl Oncol"},{"issue":"7","key":"1528_CR23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/hepr.13767","volume":"52","author":"CK He","year":"2022","unstructured":"He CK, Li ZB, Yi D, Zhu XY, Liu RR, Zhang DX, et al. LncRNA FGD5-AS1 enhances the proliferation and stemness of hepatocellular carcinoma cells through targeting miR-223 and regulating the expression of ECT2 and FAT1. Hepatol Res. 2022;52(7):614\u201329. https:\/\/doi.org\/10.1111\/hepr.13767.","journal-title":"Hepatol Res"},{"issue":"7","key":"1528_CR24","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.dld.2022.11.024","volume":"55","author":"E Lv","year":"2023","unstructured":"Lv E, Sheng J, Yu C, Rao D, Huang W. Long noncoding RNA MAPKAPK5-AS1 promotes metastasis through regulation miR-376b-5p\/ECT2 axis in hepatocellular carcinoma. Dig Liver Dis. 2023;55(7):945\u201354. https:\/\/doi.org\/10.1016\/j.dld.2022.11.024.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"1528_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00294-021-01174-3","volume":"67","author":"J Chen","year":"2021","unstructured":"Chen J, \u00dcnal E. Meiotic regulation of the Ndc80 complex composition and function. Curr Genet. 2021;67(4):511\u20138. https:\/\/doi.org\/10.1007\/s00294-021-01174-3.","journal-title":"Curr Genet"},{"issue":"20","key":"1528_CR26","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.3748\/wjg.v23.i20.3675","volume":"23","author":"LL Ju","year":"2017","unstructured":"Ju LL, Chen L, Li JH, Wang YF, Lu RJ, Bian ZL, et al. Effect of NDC80 in human hepatocellular carcinoma. World J Gastroenterol. 2017;23(20):3675\u201383. https:\/\/doi.org\/10.3748\/wjg.v23.i20.3675.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1528_CR27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.arcmed.2022.03.003","volume":"53","author":"J Li","year":"2022","unstructured":"Li J, Xu X, Peng X. NDC80 enhances cisplatin-resistance in Triple-negative breast Cancer. Arch Med Res. 2022;53(4):378\u201387. https:\/\/doi.org\/10.1016\/j.arcmed.2022.03.003.","journal-title":"Arch Med Res"},{"issue":"7","key":"1528_CR28","doi-asserted-by":"publisher","first-page":"478","DOI":"10.21037\/atm.2020.03.94","volume":"8","author":"W Xie","year":"2020","unstructured":"Xie W, Wang B, Wang X, Hou D, Su H, Huang H. Nine hub genes related to the prognosis of HBV-positive hepatocellular carcinoma identified by protein interaction analysis. Ann Transl Med. 2020;8(7):478. https:\/\/doi.org\/10.21037\/atm.2020.03.94.","journal-title":"Ann Transl Med"},{"issue":"9","key":"1528_CR29","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1182\/blood.2021012334","volume":"139","author":"SN Wontakal","year":"2022","unstructured":"Wontakal SN, Britto M, Zhang H, Han Y, Gao C, Tannenbaum S, et al. RACGAP1 variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the disease. Blood. 2022;139(9):1413\u20138. https:\/\/doi.org\/10.1182\/blood.2021012334.","journal-title":"Blood"},{"issue":"8","key":"1528_CR30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1182\/blood.2021012882","volume":"140","author":"MG Klatt","year":"2022","unstructured":"Klatt MG, Dao T, Yang Z, Liu J, Mun SS, Dacek MM, et al. A TCR mimic CAR T cell specific for NDC80 is broadly reactive with solid tumors and hematologic malignancies. Blood. 2022;140(8):861\u201374. https:\/\/doi.org\/10.1182\/blood.2021012882.","journal-title":"Blood"},{"issue":"7170","key":"1528_CR31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nature05993","volume":"450","author":"W Hu","year":"2007","unstructured":"Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature. 2007;450(7170):721\u20134. https:\/\/doi.org\/10.1038\/nature05993.","journal-title":"Nature"},{"issue":"7","key":"1528_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrm4007","volume":"16","author":"F Kruiswijk","year":"2015","unstructured":"Kruiswijk F, Labuschagne CF, Vousden KH. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol. 2015;16(7):393\u2013405. https:\/\/doi.org\/10.1038\/nrm4007.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1528_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ebiom.2017.05.017","volume":"20","author":"C Tanikawa","year":"2017","unstructured":"Tanikawa C, Zhang YZ, Yamamoto R, Tsuda Y, Tanaka M, Funauchi Y, et al. The Transcriptional Landscape of p53 signalling pathway. EBioMedicine. 2017;20:109\u201319. https:\/\/doi.org\/10.1016\/j.ebiom.2017.05.017.","journal-title":"EBioMedicine"},{"key":"1528_CR34","doi-asserted-by":"publisher","first-page":"107720","DOI":"10.1016\/j.pharmthera.2020.107720","volume":"220","author":"J Huang","year":"2021","unstructured":"Huang J. Current developments of targeting the p53 signaling pathway for cancer treatment. Pharmacol Ther. 2021;220:107720. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107720.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"1528_CR35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","volume":"39","author":"JM Suski","year":"2021","unstructured":"Suski JM, Braun M, Strmiska V, Sicinski P. Targeting cell-cycle machinery in cancer. Cancer Cell. 2021;39(6):759\u201378. https:\/\/doi.org\/10.1016\/j.ccell.2021.03.010.","journal-title":"Cancer Cell"}],"updated-by":[{"DOI":"10.1186\/s13000-024-01543-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000}}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01528-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-024-01528-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-024-01528-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T06:04:20Z","timestamp":1724997860000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-024-01528-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1528"],"URL":"https:\/\/doi.org\/10.1186\/s13000-024-01528-8","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s13000-024-01543-9","asserted-by":"object"}]},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13000-024-01543-9","URL":"https:\/\/doi.org\/10.1186\/s13000-024-01543-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}